Evimeter
Because Evidence Matters
Consilium Scientific is developing Evimeter to visually assess and compare clinical evidence for innovative medical technologies
Clinical decision making depends on transparent and interpretable evidence, yet for many emerging medical technologies the available evidence is heterogeneous, incomplete, and difficult to interpret. This challenge is particularly acute for innovative medical devices and diagnostics that enter clinical use with limited comparative data. Whilst the 21st Century Cures Act aimed to accelerate innovation and modernize Medicare coverage processes, gaps remain in how evidence quantity and quality are evaluated and communicated during coverage and reimbursement decisions.
Consilium Scientific’s development of Evimeter addresses the need for an appraisal framework that can translate complex clinical evidence into standardized, accessible formats that make uncertainty explicit across diverse clinical domains. Our evidence grading tool is currently being tested on emerging medical technologies (that are temporarily coded by the American Medical Association as Category III for billing purposes) and compared against a matched set of clinically established, widely adopted technologies (coded as Category I).
The Evimeter initiative will benefit Medicare Administrative Contractors (MACs) – regional private organizations contracted by the federal government to determine whether specific medical technologies will be covered by Medicare – and other stakeholders such as clinicians, policymakers and, eventually, patients.
This research is funded by Arnold Ventures
Project Outputs:
- Methodology publication
- Evimeter prototype
- Case studies of Evimeter application on least 5 products
- Products selected for evaluation will be published here in May 2025
- Policy paper
Project Outputs:
- Methodology publication
- Evimeter prototype
- Case studies of Evimeter application on least 5 products
- Products selected for evaluation will be published here in May 2025
- Policy paper
